Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Research

| More

Tata Consultancy Services - Steady state growth / margins are yet to be seen! - ICICI Securities

Posted On: 2021-01-12 03:22:22 (Time Zone: Arizona, USA)


Segments like regional markets (+7.3% QoQ, CC), manufacturing (+7.1%) and communications (+5.5%), which did not fully recover in Sep'20, led Q3 growth. Near- term growth (H1CY21) will be optically strong, courtesy - 1) low base effect (prior 2 years), and 2) ramp-up of captive / large deals. However, as focus shifts from 'recovery' to 'growth', steady-state growth (Sep-21++) will be the key monitorable. Sustainability of utilisation and offshore effort, seemingly at their peaks, is a big ask. Reversal of some Covid-led savings, large deal ramp-ups and weaker USD can upset street expectation of further margin expansion. Despite decelerating growth and stable return ratios, near-zero interest rates / liquidity led to expanding multiples over FY10-FY20. As highlighted in our thematic report, Covid gave a further impetus to valuations v/s business case of the sector. However, this time, both the pace and quantum of TCS' multiple expansion (~45%, LTM) is unprecedented and alarming - both on absolute and relative basis. In conjunction with earlier highlighted sector risks (thematic, Outlook2021), we downgrade the stock to ADD (from Buy).

- Stronger-than-expected revenue growth and margins. Revenue growth (4.1% QoQ, CC) was ahead of our expectation (3% QoQ). While growth was broad-based across geographies, the beat was driven by robust expansion in non-core geographies like India (+18.1% QoQ) and MEA (+6.7% QoQ). As we highlighted in our preview, the theme of residual recovery played out during Dec'20. Segments like regional markets (+7.3%), manufacturing (+7.1%) and communications & media (+5.5%), which did not fully recover in Sep'20, delivered strong growth during Dec'20. Despite a sturdy base, Life Sciences & Healthcare (+5.2%) continued to shine possibly led by Covid-related ad hoc work. Factors like budget flush, large deal ramp ups seem to have helped too.

The bigger surprise is in the reported ~40bps QoQ expansion in EBIT margin, despite salary hikes. While the hikes impacted margins by ~160bps, it was more than offset by utilisation / productivity improvements and offshore shift during the quarter.

- Healthy deal-win momentum; near-term outlook strong. Large-deal TCV remained healthy (US$6.8bn ex-Postbank vs US$6.1bn in Sep'20 ex-Phoenix). Management hinted at an aspiration for delivering double-digit growth and EBIT margins in the range of 26-28% over CY21/FY22. Optically strong growth in both Q4FY21 and FY22 is a given, aided by 1) ramp-up of recent captive takeovers / other large deals, and 2) low base effect (both FY21 & FY20). Nevertheless, it should be noted that revenue CAGR (CC) over FY19-FY22E (more reliable reflection of growth over this horizon) would still be ~6.5% -- lower than historical and even FY19 levels.

- Sustainable metrics / risks will be the key going ahead. Investor focus so far has been largely anchored to cyclical 'recovery' from the Covid troughs. IT sector, in general, and TCS, have shown phenomenal resilience on this count over H2CY20. As the focus shifts to sustainable metrics, growth rates in Sep-21 and beyond will be the key thing to watch out for (without Covid distortion in base).

Many of the one-time margin tailwinds that TCS witnessed in FY21 (e.g. absence of travel, marketing events, facility expenses and offshore shift, etc.) will likely reverse from Sep-21 and beyond. New margin headwinds could emerge too (e.g. weaker USD, captive integrations, large deal ramp-ups, etc.). Post the recent takeover of US Senate control by Democrats, potential risk of rise in corporate taxes cannot be ruled out. Subject to the quantum of rise, consensus estimates up to ~12% impact on corporate profitability in the US. Accordingly, we see a risk for downstream players like Indian IT companies including TCS.

- Multiples rerated too much and too fast. Above risks assume further importance in the context of a recent sharp run-up in the valuations. As highlighted in our Oct'20 thematic, expanding multiples of TCS (the broader markets in general) over the last decade surprised the value-conscious investors from time to time. This was despite the sharp growth deceleration and largely stable return ratios. Prolonged period of near-zero interest rates, high liquidity, increased trend of buybacks, and reduction in taxation were the major contributing factors.

This trend accentuated post-Covid with another round of liquidity entering into the market. To some extent, higher than market rerating was understandable for IT sector given its relatively better resilience and business continuity. However, we are alarmed by the pace and magnitude of TCS' rerating, both of which are unprecedented (45%, LTM). As we rebase our exchange rate assumptions and rethink our expected margin trajectory, our earnings estimates over FY22-23E witness 1-5% downward revisions (contrary to consensus). On our revised estimates, stock is trading at 31x FY22E EPS (v/s historical average of 19x).

While the decade in the run-up to Covid had seen TCS' stock trading at an average ~10% premium to NIFTY, the stock is currently trading at ~42% premium. Likewise, the stock now trades at a premium to Big Tech stocks where consensus' revenue growth expectations are relatively higher (e.g. Facebook, Alphabet). In that context, we stay cautious on the valuations especially since we don't expect any material growth acceleration (vs pre-Covid) in the steady-state post Covid. Post our re-initiation of coverage with a BUY rating in Oct'20, the stock was up ~15%. We see any potential rally on back of this result to be a good profit booking opportunity. Downgrade to ADD.

Shares of TATA CONSULTANCY SERVICES LTD. was last trading in BSE at Rs.3175.05 as compared to the previous close of Rs. 3120.35. The total number of shares traded during the day was 253600 in over 18332 trades.

The stock hit an intraday high of Rs. 3224 and intraday low of 3147.45. The net turnover during the day was Rs. 804977931.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.





Other Headlines:

Union Budget 2021-22 - Preview Report - YES SECURITIES

Alembic Pharma (Q3 FY21) - 'First signs of sartans weakness' - YES Securities

CSB Bank Q3 Earnings Call - Key Takeaways - YES Securities

ICICI Lombard - Q3FY21 Result Report - YES Securities

Gateway Distriparks - Q3FY21 - Multiple triggers at play - ICICI Securities

Prince Pipes and Fittings - Improving governance; rerating inevitable - ICICI Securities

CEAT - Margins resilient due to healthy replacement mix - ICICI Securities

Hatsun Agro Products - Commencement of three plants and lower tax rate to boost return ratios in FY22 and beyond - ICICI Securities

Alembic Pharmaceuticals - India recovers, US sees pressure - ICICI Securities

Q3FY21 Result update - MindTree Ltd - ICICI Direct

Q3FY21 Company update - Shoppers Stop - ICICI Direct

IPO - Indigo Paints Ltd - ICICI Direct

Larsen & Toubro Infotech Ltd - Q3FY21 First Cut - ICICI Direct

Tata Communications - Q3FY21 First Cut - ICICI Direct

Maintain ADD on Mindtree - Into another operating orbit - HDFC Securities

NBFCs Q3FY21 Results Preview - Micro headwinds > Macro tailwinds - HDFC Securities

Mindtree - Margin beat and raise cycle seems to be over! - ICICI Securities

Shoppers Stop - Focusing on omni-channel growth - ICICI Securities

Piramal Enterprises - Strategic synergies, optional value to follow DHFL's buyout - ICICI Securities

Motherson Sumi Systems - Focus remains on growth and cost efficiency - ICICI Securities

Metropolis Healthcare - Acquires Hitech Diagnostics in South India - ICICI Securities

Nifty PE shifting orbits - ICICI Direct

Rallis India Ltd - Q3FY21 First Cut - ICICI Direct

Q3FY21 Company update - GTPL Hathway - ICICI Direct

Q3FY21 Result update - HDFC Bank - ICICI Direct

Q3FY21 Result Update - PVR Ltd - ICICI Direct

Q3FY21 Result update - HCL Technologies - ICICI Direct

Maintain BUY on HCL Technologies - Mode-2, 3 driven momentum - HDFC Securities

HDFC Bank Q3FY21 Results - Concall Highlights and Views of YES SECURITIES

HDFC Bank Q3 FY21 - 'Stellar Show' - Retain BUY and raise 12m PT to Rs1870 - YES Securities

IPO Review - Indian Railway Finance Corporation (IRFC) - ICICI Direct

HCL Technologies - Q3FY21 First Cut - ICICI Direct

Logistics Sector Update - Indian Railways - getting aggressive - HDFC Securities

Indigo Paints - IPO view - YES SECURITIES

Infosys - Near-term margins will likely come under pressure - ICICI Securities

CESC - 7% dividend yield + higher ESG rating - ICICI Securities

South Indian Bank - Unveils vision 2024; targets RoA / RoE of 1% / 13% by 2024 - ICICI Securities

Maintain BUY on Infosys - Growth certainty on explosive deal wins - HDFC Securities

Maintain ADD on Wipro - Growth acceleration - HDFC Securities

Consumer Durables - Q3FY21 Results Preview - HDFC Securities

Q3FY21 Company Update - Filatex India - ICICI Direct

Q3FY21 Result Update - Wipro Ltd - ICICI Direct

Q3FY21 Result Update - CESC - ICICI Direct

Monthly Inflation - December 2020 - ICICI Direct

Q3FY21 Result Update - Infosys - ICICI Direct

Banks Q3FY21 Results Preview - Scope for optimism beyond a tepid 3Q - HDFC Securities

Consumer Discretionary Companies - Q3FY21 Results Preview Report - HDFC Securities

Pharma Sector Update - Ample catalysts to sustain luster - HDFC Securities

Suman Chowdhury, Chief Analytical Officer, Acuité Ratings & Research on IIP data

Infosys - Q3FY21 First Cut - ICICI Direct



Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020